NewAmsterdam Pharma Company N.V. Stock BOERSE MUENCHEN
Equities
KH6
NL00150012L7
Biotechnology & Medical Research
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
16.3 EUR | +0.62% |
|
-11.48% | 0.00% |
Sales 2024 * | 8.6M 9.2M | Sales 2025 * | 6.3M 6.73M | Capitalization | 1.45B 1.55B |
---|---|---|---|---|---|
Net income 2024 * | -209M -223M | Net income 2025 * | -139M -149M | EV / Sales 2024 * | 168 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 230 x |
P/E ratio 2024 * |
-6.89
x | P/E ratio 2025 * |
-10.7
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.29% |
Latest transcript on NewAmsterdam Pharma Company N.V.
1 week | -11.48% | ||
Current month | -5.26% | ||
1 month | -11.48% | ||
3 months | -19.80% |
![Extreme 15.9](/images/extremecours_fleche.png)
![Extreme 15.9](/images/extremecours_fleche.png)
Date | Price | Change |
---|---|---|
24-06-21 | 16.3 | +0.62% |
24-06-20 | 16.2 | +0.62% |
24-06-19 | 16.1 | +1.26% |
24-06-18 | 15.9 | -6.47% |
24-06-17 | 17 | -3.95% |
Real-time BOERSE MUENCHEN, June 21, 2024 at 05:43 am EDT
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.85% | 122B | |
+18.91% | 113B | |
+7.48% | 22.84B | |
-18.63% | 20.72B | |
-13.76% | 16.39B | |
-15.82% | 16.51B | |
-43.53% | 15.83B | |
+1.75% | 13.49B | |
+28.07% | 11.67B |
- Stock Market
- Equities
- NAMS Stock
- KH6 Stock